79927-75-6 Usage
Uses
Used in Oncology:
2,6-DIMETHYLTHIENO[2,3-D]PYRIMIDIN-4-OL is used as a therapeutic agent for managing cancer-related cachexia, a wasting syndrome characterized by significant weight loss and muscle atrophy. It is employed to improve appetite, muscle mass, and overall body composition in these patients, thereby potentially enhancing their quality of life and treatment outcomes.
Used in Advanced Non-Small Cell Lung Cancer Treatment:
In the field of oncology, 2,6-DIMETHYLTHIENO[2,3-D]PYRIMIDIN-4-OL is used as a treatment to stimulate weight gain in patients with advanced non-small cell lung cancer. Its ability to promote appetite and muscle mass can contribute to better physical condition and potentially improve the efficacy of other cancer treatments.
Used in Enhancing Skeletal Muscle Strength and Function:
2,6-DIMETHYLTHIENO[2,3-D]PYRIMIDIN-4-OL is utilized to improve skeletal muscle strength and function, which can be particularly beneficial for patients with muscle-wasting conditions or those who have experienced significant muscle deterioration due to illness or injury.
While anamorelin has shown promise in these applications, ongoing research is essential to fully elucidate its effects, optimize its therapeutic potential, and establish its place in clinical practice.
Check Digit Verification of cas no
The CAS Registry Mumber 79927-75-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,9,9,2 and 7 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 79927-75:
(7*7)+(6*9)+(5*9)+(4*2)+(3*7)+(2*7)+(1*5)=196
196 % 10 = 6
So 79927-75-6 is a valid CAS Registry Number.
79927-75-6Relevant academic research and scientific papers
THIENO[2,3-D)PYRIMIDINES AND BENZOFURO(3,2-D)PYRIMIDINES AS ANTIMICROBIAL AGENTS
-
Page/Page column 100, (2019/02/06)
The present disclosure provides compounds, methods, and compositions which may be used to treat tuberculosis. In some embodiments, these compounds and compositions have a bactericidal property against Mycobacterium tuberculosis (Mtb). Methods of employing such agents are also provided.
NOVEL THIENO-PYRIDINE AND THIENO-PYRIMIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2-RECEPTORS
-
Page/Page column 57-58, (2010/10/20)
The present invention relates to novel compounds, in particular novel thieno-pyridine and thieno-pyrimidine derivatives according to Formula (I), wherein all radicals are defined in the application. The compounds according to the invention are positive al
